This shift enhances tumour cell elimination by promoting phagocytosis, tumour antigen presentation, and the production of pro-inflammatory cytokines and chemokines, such as TNF-α, CXCL9, CXCL10, and IL-1 (37–41). The gene discussed is CXCL9; the disease is neoplasm.